These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20621175)

  • 1. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
    Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ
    J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
    Formentini EA; Mestorino N; Errecalde JO
    Vet Res Commun; 2005 Oct; 29(7):595-608. PubMed ID: 16142607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hydroxypropyl-beta-cyclodextrin and sucrose on the sublingual absorption of midazolam in rabbits.
    Kaartama R; Turunen E; Toljamo K; Kokki H; Lehtonen M; Ranta VP; Savolainen J; Järvinen K; Jarho P
    Eur J Pharm Biopharm; 2012 May; 81(1):178-83. PubMed ID: 22321528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
    Wu Z; Razzak M; Tucker IG; Medlicott NJ
    J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
    Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
    J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
    Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
    Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S; Diwan PV
    Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves.
    Lanusse CE; Virkel GL; Sanchez SF; Alvarez LI; Lifschitz AL; Imperiale F; Monfrinotti A
    Res Vet Sci; 1998; 65(1):5-10. PubMed ID: 9769065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma.
    Wu Z; Medlicott NJ; Razzak M; Tucker IG
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):225-32. PubMed ID: 15878252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
    Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ
    Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
    Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
    Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ricobendazole in calves.
    Formentini EA; Mestorino ON; Mariño EL; Errecalde JO
    J Vet Pharmacol Ther; 2001 Jun; 24(3):199-202. PubMed ID: 11442798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review.
    Gould S; Scott RC
    Food Chem Toxicol; 2005 Oct; 43(10):1451-9. PubMed ID: 16018907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.